Tuesday, August 2, 2016

US FDA announces approval for generic Glumetza

Sun Pharma  today announced that one of its subsidiaries has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Glumetza, Metformin Hydrochloride extended release tablets 500 mg and 1000 mg.
These Metformin Hydrochloride extended release tablets are therapeutic equivalents of Santarus Inc.’s Glumetza 

For more information view website